Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Activity of Indoleamine 2,3-dioxygenase in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT01397916 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT01397916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01397916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Activity of Indoleamine 2,3-dioxygenase in Patients With Chronic Lymphocytic Leukemia (CLL)
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Completed
Start date
February 28, 2010
Completion date
December 31, 2010
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cll